tiprankstipranks
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
US Market

Mirum Pharmaceuticals (MIRM) Ownership - Who Owns Mirum Pharmaceuticals?

Compare
671 Followers

Mirum Pharmaceuticals (MIRM) Ownership Overview

9.65%26.31%41.45%12.30%10.30%
41.45% Other Institutional Investors
12.30% ETFs
10.30% Public Companies and Individual Investors
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 80.05% of the company’s stock is owned by Institutional Investors, 9.65% is owned by Insiders, and 10.30% is owned by Public Companies and Individual Investors.
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 67.75% of the company’s stock is owned by Institutional Investors, 9.65% is owned by Insiders, and 12.30% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 04, 2025
Peter Radovich
President & Coo
xxxxxxxxxxxxx
$126674
Feb 04, 2025
Christopher Peetz
Ceo,director
xxxxxxxxxxxxx
$438898
Jan 08, 2025
Peter Radovich
President & Coo
xxxxxxxxxxxxx
$85534
Jan 08, 2025
Christopher Peetz
Ceo,director
xxxxxxxxxxxxx
$320604

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$7410000
Dec 31, 2024
xxxxxxxxxxxxx
$12909195

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,729,220Insider7.77%186,610,169
3,482,416Institution7.25%174,260,097
2,270,257Institution4.73%113,603,660
2,022,070Institution4.21%101,184,383
1,996,358Institution4.16%99,897,754
1,924,093Institution4.01%96,281,614
768,367Institution1.60%38,449,085
652,011Institution1.36%32,626,630
648,193Institution1.35%32,435,578
563,468Institution1.17%28,195,939

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,482,416Institution7.25%174,260,097
2,022,070Institution4.21%101,184,383
1,996,358Institution4.16%99,897,754
768,367Institution1.60%38,449,085
652,011Institution1.36%32,626,630
648,193Institution1.35%32,435,578
427,538Institution0.89%21,394,002
404,954Institution0.84%20,263,898
320,574Institution0.67%16,041,523
270,400Institution0.56%13,530,816

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,301,551Institution2.71%53,819,134
1,066,296Institution2.22%53,357,452
606,471Institution1.26%25,077,576
483,433Institution1.01%24,510,053
353,573Institution0.74%17,692,793
239,485Institution0.50%11,983,829
194,992Institution0.41%9,886,094
188,554Institution0.39%7,796,708
115,809Institution0.24%4,788,702
91,228Institution0.19%4,565,049

FAQ

Who Owns Mirum Pharmaceuticals Inc (MIRM)?
According to the latest TipRanks data, approximately 41.45% of the company's stock is held by institutional investors, 9.65% is held by insiders, and 10.30% is held by retail investors.
    What percentage of Mirum Pharmaceuticals Inc (MIRM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 41.45% of Mirum Pharmaceuticals Inc (MIRM) stock is held by institutional investors.
      What percentage of Mirum Pharmaceuticals Inc (MIRM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 10.30% of Mirum Pharmaceuticals Inc (MIRM) stock is held by retail investors.
        Who owns the most shares of Mirum Pharmaceuticals Inc (MIRM)?
        Patrick Heron owns the most shares of Mirum Pharmaceuticals Inc (MIRM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis